Pear 20 mg (Capsule (Enteric Coated))
Unit Price: ৳ 4.50
Medicine Details
Category | Details |
---|---|
Generic | Omeprazole |
Company | Prime pharmaceuticals ltd |
Indications
- Gastric and duodenal ulcer
- NSAID-associated duodenal and gastric ulcer
- As prophylaxis in patients with a history of NSAID-associated duodenal and gastric ulcer
- Gastro-esophageal reflux disease
- Long-term management of acid reflux disease
- Acid-related dyspepsia
- Severe ulcerating reflux esophagitis
- Prophylaxis of acid aspiration during general anesthesia
- Zollinger-Ellison syndrome
- Helicobacter pylori-induced peptic ulcer
Pharmacology
- Inhibitor of gastric acid secretion
- Blocks hydrogen-potassium-adenosine triphosphatase (H+/K+ ATPase) enzyme system
- Onset of antisecretory effect occurs within one hour
- Maximum effect within two hours
- Inhibition of secretion lasts up to 72 hours
Dosage
- 20 mg once daily for benign gastric and duodenal ulcer
- 8 weeks in gastric ulceration
- 40 mg daily for severe or recurrent cases
- Maintenance dose for recurrent duodenal ulcer - 20 mg once daily
- 10-20 mg daily for long-term acid reflux disease management
- 10-20 mg once daily for acid-related dyspepsia
- 40 mg on the preceding evening for prophylaxis of acid aspiration
- Initial dose of 60 mg once daily for Zollinger-Ellison syndrome
- 20 mg twice daily for Helicobacter pylori eradication regimen in peptic ulcer disease
- 10-20 mg once daily for severe ulcerating reflux esophagitis (pediatric use)
Administration
- Intravenous administration only
- Slow intravenous injection
- Intravenous infusion over a period of 20-30 minutes
- Reconstituted solution should be used within 4 hours of reconstitution
Interaction
- Decreased intragastric acidity affecting ketoconazole absorption
- Metabolised in the liver through cytochrome P450
- Can delay the elimination of diazepam, phenytoin, and warfarin
- Plasma concentrations are increased during concomitant administration
Contraindications
- Known hypersensitivity to Omeprazole
- Exclusion of malignancy before treatment with omeprazole
Side Effects
- Skin rash, urticaria, and pruritus
- Photosensitivity, bullous eruption, and erythema multiforme
- Diarrhea and headache
- Gastrointestinal reactions including constipation and nausea/vomiting
- Dry mouth, stomatitis, and candidiasis
- Dizziness, lightheadedness, and feeling faint
- Reversible mental confusion, agitation, and depression
- Arthritic and myalgic symptoms
- Increases in liver enzymes
Pregnancy & Lactation
- No adverse effects on pregnancy or fetus/newborn child
- Can be used during pregnancy
- No information available on passage into breast milk or effects on the neonate
Precautions & Warnings
- Avoid concomitant use of clopidogrel and Omeprazole
- Proton pump inhibitor (PPI) therapy may be associated with an increased risk for osteoporosis-related fractures
- Atrophic gastritis noted in patients treated long-term with Omeprazole
- Concomitant use of PPIs with methotrexate may lead to methotrexate toxicities
Therapeutic Class
- Proton Pump Inhibitor
Storage Conditions
- Keep in a dry place away from light and heat
- Keep out of the reach of children
Related Brands
- Anasec 20 mg (Capsule (Enteric Coated)) - novo-healthcare-and-pharma-ltd
- Anasec 40 mg/vial (IV Injection) - novo-healthcare-and-pharma-ltd
- Aspra 20 mg (Capsule (Enteric Coated)) - apex-pharmaceuticals-ltd
- AU-20 20 mg (Capsule (Enteric Coated)) - decent-pharma-laboratories-ltd
- Aumi 20 mg (Capsule (Enteric Coated)) - hudson-pharmaceuticals-ltd